banner
DPP-4 inhibitor BI-1356, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ710

DPP-4 inhibitor BI-1356, Purity ≥98%

Synonym: 668270-12-0; DPP-4 inhibitor; BI-1356; Tradjenta; Trajenta

  • MDL: MFCD14635356
  • CAS Number: 668270-12-0
  • Compound CID: 10096344
img
Product Size
100 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
BI-1356, soluble in DMSO and ethanol and insoluble in water, prolongs the action of incretin hormones, thereby improving blood glucose control. It targets DPP-4.
Molecular Weight
472.5
Molecular Formula
C25H28N8O2
Targets
DPP-4: 1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 16 mg/mL (33.85 mM); Water: Insoluble; Ethanol: 1 mg/mL (2.11 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BI-1356 is used in studies targeting DPP-4 inhibition, contributing to diabetes research and treatment development.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0